...
首页> 外文期刊>Cardiovascular Diabetology >Acute hyperglycemia abolishes cardioprotection by remote ischemic perconditioning
【24h】

Acute hyperglycemia abolishes cardioprotection by remote ischemic perconditioning

机译:急性高血糖症消除了远程缺血性心肌病对心脏的保护作用

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Remote ischemic perconditioning (RIPerC) has a promising therapeutic insight to improve the prognosis of acute myocardial infarction. Chronic comorbidities such as diabetes are known to interfere with conditioning interventions by modulating cardioprotective signaling pathways, such as e.g., mTOR pathway and autophagy. However, the effect of acute hyperglycemia on RIPerC has not been studied so far. Therefore, here we investigated the effect of acute hyperglycemia on cardioprotection by RIPerC. Wistar rats were divided into normoglycemic (NG) and acute hyperglycemic (AHG) groups. Acute hyperglycemia was induced by glucose infusion to maintain a serum glucose concentration of 15–20?mM throughout the experimental protocol. NG rats received mannitol infusion of an equal osmolarity. Both groups were subdivided into an ischemic (Isch) and a RIPerC group. Each group underwent reversible occlusion of the left anterior descending coronary artery (LAD) for 40?min in the presence or absence of acute hyperglycemia. After the 10-min LAD occlusion, RIPerC was induced by 3 cycles of 5-min unilateral femoral artery and vein occlusion and 5-min reperfusion. After 120?min of reperfusion, infarct size was measured by triphenyltetrazolium chloride staining. To study underlying signaling mechanisms, hearts were harvested for immunoblotting after 35?min in both the NG and AHG groups. Infarct size was significantly reduced by RIPerC in NG, but not in the AHG group (NG?+?Isch: 46.27?±?5.31?% vs. NG?+?RIPerC: 24.65?±?7.45?%, p?
机译:远程缺血性适应症(RIPerC)在改善急性心肌梗死的预后方面具有广阔的治疗前景。已知诸如糖尿病的慢性合并症通过调节心脏保护性信号传导途径例如mTOR途径和自噬来干扰调节干预。但是,到目前为止,尚未研究急性高血糖对RIPerC的影响。因此,在这里我们研究了急性高血糖对RIPerC的心脏保护作用。 Wistar大鼠分为正常血糖(NG)组和急性高血糖(AHG)组。在整个实验方案中,葡萄糖输注可引起急性高血糖,使血清葡萄糖浓度维持在15–20?mM。 NG大鼠接受等渗的甘露醇输注。两组均分为缺血组(Isch)和RIPerC组。在存在或不存在急性高血糖症的情况下,每组接受左冠状动脉前降支(LAD)可逆性阻塞40分钟。 LAD闭塞10分钟后,通过3次5分钟单侧股动脉和静脉闭塞以及5分钟再灌注来诱导RIPerC。再灌注120分钟后,通过氯化三苯基四唑鎓测定梗塞面积。为了研究潜在的信号传导机制,NG和AHG组在35分钟后收集心脏进行免疫印迹。在NG中,RIPerC可显着减少梗死面积,但在AHG组中则无此效果(NG + Isch:46.27±5.31%,而NG + RIPerC:24.65±7.45%,p <<? 0.05; AHG + + Isch:54.19±±4.07%,对52.76±±3.80%。急性高血糖症本身并不影响梗塞面积,但会显着增加心律不齐的发生率和持续时间。急性高血糖激活雷帕霉素(mTOR)途径的机制靶标,因为它显着增加了mTOR和S6蛋白的磷酸化以及AKT的磷酸化。尽管降低了LC3II / LC3I比率,但自噬的其他标志物(如ATG7,ULK1磷酸化,Beclin 1和SQSTM1 / p62)不受急性高血糖症的调节。此外,急性高血糖症显着提高了心脏的硝化应激(0.87±±0.01 0.01 vs. 0.50±±0.04μg3-硝基酪氨酸/ mg蛋白,p <0.05)。这是急性高血糖会削弱RIPerC的心脏保护作用的第一个证明。这种现象的机制可能涉及急性高血糖诱导的硝化应激增加和mTOR通路的激活。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号